Abstract
Under oxygen-limited conditions, the adaptability and underlying mechanisms of bacterial biofilms have become key areas of interest in microbiology and clinical infection research. Within biofilms—composed of bacterial communities and extracellular matrix—an oxygen gradient commonly forms, resulting in hypoxic or even anoxic microenvironments. Such conditions substantially increase biofilm antibiotic resistance and facilitate the persistence of chronic infections. This review systematically summarizes the adaptive strategies employed by biofilms in hypoxic environments, including anaerobic metabolism, phenazine-mediated electron shuttling, and virulence factor regulation. These adaptive responses are governed by genes involved in anaerobic metabolism, quorum sensing systems, and the secondary messenger 3,5-cyclic diguanylic acid (c-di-GMP), which collectively influence biofilm formation. Key transcriptional regulators such as Anr and Dnr, the two-component system NarXL, along with specific functional genes, form an intricate regulatory network. This article aims to provide a comprehensive overview of the adaptive mechanisms of Pseudomonas aeruginosa biofilms under oxygen-limited conditions, providing a theoretical foundation for the development of novel anti-infective therapies, targeting the biofilm infection microenvironment in cystic fibrosis and chronic wounds.
1 Introduction
Pseudomonas aeruginosa is a widely distributed Gram-negative bacterium known to cause nosocomial infections and potentially fatal infections in immunocompromised patients (; ). It is also a persistent colonizer of the lungs in cystic fibrosis (CF) patients, where it is notoriously difficult to eradicate (). During chronic infections, P. aeruginosa predominantly exists in biofilm form. Bacterial biofilms adhere to biological or abiotic surfaces and consist of bacterial communities embedded within an extracellular matrix (ECM), comprising proteins, polysaccharides, and extracellular DNA (eDNA), among other components (). These molecules provide structural integrity and facilitate intercellular adhesion (; ). Unlike planktonic bacteria, biofilms exhibit altered growth rates, metabolism, and gene expression profiles (). Bacteria in the inner layers of biofilms adapt to low metabolic activity and undergo anaerobic respiration. Due to the protective barrier of the ECM, biofilm-associated bacteria demonstrate increased antibiotic resistance by approximately 10- to 1000-fold (; ). Consequently, biofilms are inherently difficult to treat, leading to persistent and chronic infections that pose significant clinical challenges (Zhao et al., 2023a). It is estimated that 65% to 80% of human bacterial infections are associated with biofilms (Zhao et al., 2023a; ), underscoring the critical need to eradicate pathogenic biofilms for effective management of chronic infections.
Biofilm formation is a complex process influenced by various external factors, including nutrients, osmotic pressure, temperature, and oxygen availability (). The human body presents numerous low-oxygen or anaerobic niches. For example, P. aeruginosa grows as biofilms in the lungs of CF patients, where chronic infection leads to hypoxic or even anaerobic conditions (; ). Similarly, Salmonella colonizes anaerobic niches within the intestinal tract (), and oxygen concentrations in infected or necrotic tissues and wounds are notably low (). In vitro studies have confirmed that oxygen gradients are commonly present in bacterial biofilms, including those formed by P. aeruginosa (), Staphylococcus aureus (), and Enterococcus faecalis (), particularly in mature biofilms (). This oxygen limitation enhances pathogen virulence and survival (). Using oxygen microelectrode technology, localized hypoxia within P. aeruginosa biofilms has been confirmed, which restricts protein synthesis in mature biofilm interiors and contributes to antibiotic resistance (). Oxygen deficiency accounts for at least 70% of antibiotic resistance in mature P. aeruginosa biofilm cells, highlighting oxygen concentration as a critical factor in biofilm formation and multidrug resistance stability. Understanding how bacteria rapidly sense and respond to oxygen-limited environments is essential for improving infection treatments. This review summarizes the adaptations and mechanisms of P. aeruginosa biofilms under oxygen-limited conditions, aiming to provide a novel approach for eradicating biofilms through modulation of the infection microenvironment.
2 Formation of oxygen-limited microenvironment
The oxygen concentration gradient is an important characteristic of bacterial biofilms. The oxygen concentration in the environment is mostly around 19.95%. Generally, an oxygen concentration ranging from 11% to 1% is regarded as hypoxic (), while an environment with less than 1% oxygen or completely devoid of oxygen is an anoxic environment (). In CF lungs, P. aeruginosa forms biofilms where oxygen penetration is severely restricted. Microelectrode measurements reveal that oxygen levels decline progressively with depth and penetrate only 50 μm from the biofilm surface (), whereas the average biofilm thickness can reach 210 μm (). Consequently, cells deep within the biofilm experience hypoxic or anoxic conditions (; ). Active protein synthesis is confined to a zone roughly 30 μm above the base (). This oxygen limitation arises from both physical and biological factors: the dense biofilm matrix and viscous CF mucus impede diffusion, while host inflammatory responses recruit neutrophils whose respiratory burst consumes oxygen (). Additionally, oxygen is consumed directly by host and bacteria respiration at the biofilm periphery, maintaining a persistent hypoxic gradient (), as shown in Figure 1. Sputum from CF patients is predominantly micro-aerobic to anaerobic (; ; ). The extent of anoxic regions correlates with bacterial load and mucus thickness, potentially occupying large portions of mucus volume (). Notably, multidrug resistance protein (MexA) is more abundant in anoxic zones, suggesting enhanced drug tolerance under hypoxia in P. aeruginosa (; ; ). Despite being a facultative anaerobe, P. aeruginosa can maintain growth under oxygen-limited conditions (), which in turn promotes robust biofilm formation ().
Figure 1
3 The effect of oxygen-limited conditions on P. aeruginosa biofilms
3.1 Anaerobic metabolism
In human host environments, pathogens encounter fluctuating oxygen levels, with adaptive responses to such fluctuations primarily occurring at the metabolic level (). Metabolism reprogramming is central to initiating bacterial tolerance mechanisms and reactivating transitions from a non-replicating to an actively growing state. P. aeruginosa exhibits remarkable metabolic versatility, utilizing diverse catabolic and anabolic pathways encoded in its genome to thrive in harsh environments (; ). While aerobic metabolism dominates under oxygen-replete conditions, biofilm-embedded bacteria frequently reside in oxygen-limited niches. Under such constraints, P. aeruginosa shifts to aerobic metabolism—enabling sustained growth and metabolic activity without oxygen (). This adaptation encompasses anaerobic respiration and fermentation, as illustrated in Figure 2. Critically, this metabolic switch confers enhanced antibiotic tolerance and specific molecule resistance ().
Figure 2
For energy generation via respiratory, P. aeruginosa can utilize oxygen, nitrogen compounds, and potentially other electron acceptors such as thiosulfate (). Under oxygen-limited conditions, P. aeruginosa performs anaerobic respiration using nitrate, nitrite, or nitrous oxide as terminal electron acceptors, facilitating rapid growth and energy production. In the absence of nitrate and nitrite, P. aeruginosa employs two alternative fermentation pathways to support slow growth or survival. The first involves substrate-level phosphorylation through arginine utilization, resulting in very slow growth. The second fermentation pathway uses pyruvate as a substrate, converting it into acetate, lactate, and small amounts of succinate.
3.1.1 Anaerobic respiration
Nitrogen metabolism under anaerobic and biofilm conditions promotes the virulence and tolerance of pathogens under hypoxic stress. Denitrification, a continuous four-step, eight-electron reduction process converting nitrate to nitrogen, is a key pathway enabling P. aeruginosa to respire anaerobically under oxygen-limited conditions (; ). In this process, nitrate (NO3-) or nitrite (NO2-) serves as the terminal electron acceptor (TEA), replacing oxygen generate energy. Denitrification also serves as an important cellular redox balancing mechanism within biofilms, provided these electron acceptors are available in sufficient concentrations (; ). Using an alginate-encapsulated P. aeruginosa chronic infection model, it has been demonstrated that oxygen depletion limits bacterial growth. Supplementing nitrate as an alternative electron acceptor sustains the growth of P. aeruginosa microcolonies under oxygen-limited conditions, although the overall respiration rate decreases (). Consistent with these findings, lower nitrate and nitrite levels have been observed in infected wounds compared to non-infected controls, reflecting bacterial consumption via denitrification (). Clinically, the ability of P. aeruginosa to perform anaerobic respiration under hypoxic conditions contributes to enhanced biofilm formation (), aligning with model predictions ().
During hypoxic growth, nitric oxide (NO) can be produced endogenously as a denitrification intermediate or derived from exogenous NO donors. NO exhibits potent bactericidal properties (). Accumulation of NO under anaerobic conditions acts as a stress signal, ultimately promoting biofilm formation as a defense mechanism (; ). NO detoxification proteins, including NO reductase (NOR, encoded by norVW) and flavohemoglobin (Hmp), help mitigate NO toxicity during denitrification (). Interestingly, nitrite reductase (NIR) also has NO-independent functions; NO can indirectly induce NIR expression and regulate flagella biosynthesis and swimming motility by forming a ternary complex with the molecular chaperone DnaK and flagellin FliC in the periplasm, serving as a scaffold ().
Beyond anaerobic respiration, P. aeruginosa in the mucus layer of CF lungs can perform microaerobic respiration. This process rapidly consumes oxygen, creating an oxygen gradient (). In the CF lung microenvironment, microaerobic respiration can occur simultaneously with nitrate respiration when both oxygen and nitrate are present (). Three high-affinity terminal oxidases—the cbb3-1, cbb3-2, and cyanide-insensitive oxidases—enable growth at low oxygen concentrations and facilitate microaerobic growth. Notably, the genes encoding cbb3–2 oxidase and the cyanide-insensitive oxidase (cioAB) are highly expressed under oxygen-limited conditions (). The cyanide-insensitive oxidases not only increase under microaerobic conditions but may also protect cells against hydrogen cyanide toxicity during growth. The cbb3–1 oxidase is consistently expressed across various oxygen levels, suggesting P. aeruginosa maintains preparedness for sudden oxygen depletion without needing to trigger a transcriptionally regulated hypoxic response ().
3.1.2 Fermentation
Under oxygen-limited and nitrate-depleted conditions, P. aeruginosa biofilms sustain other energy supply through fermentation, primarily by activating the arginine fermentation pathway () and pyruvate fermentation (), which moderately support anaerobic growth and survival. L-arginine serves as a substrate for ATP production, enabling bacterial persistence under these conditions (). Specifically, P. aeruginosa utilizes the arginine deiminase (ADI) pathway to generate energy under oxygen-limited conditions, producing 1 mole of ATP per mole of L-arginine consumed. When arginine concentrations are sufficiently high, substrate-level phosphorylation can yield enough ATP to maintain bacterial growth. Thus, denitrification and arginine fermentation represent core metabolic processes in P. aeruginosa under oxygen-limited conditions.
Additionally, under anaerobic conditions, P. aeruginosa ferments pyruvate into lactate, acetate, and succinate. Although pyruvate fermentation does not support substantial anaerobic growth, it promotes long-term bacterial viability without contributing directly to proliferation (). Proteomic analyses of hypoxic biofilm regions further suggest that cells produce fermentation by-products such as acetate (). Notably, nitrate respiration inhibits pyruvate fermentation, whereas arginine fermentation proceeds independently of pyruvate metabolism ().
3.2 Phenazines as an electron shuttle
P. aeruginosa is well known for producing colored, redox-active metabolites called phenazines (). These phenazine compounds produced vary in structure and chemical properties (), functioning as electron-cycling molecules. The redox cycling of phenazine involves alternating reduction and oxidation reactions, which reoxidize accumulated NADH, thereby facilitating the transfer of electrons from reducing agents such as NAD(P)H to oxidizing agents like oxygen. This process promotes adenosine triphosphate (ATP) production and the generation of proton-motive force, allowing cells to survive in hypoxic regions and supporting colony growth (; ). The redox potential of phenazines enables their reduction by bacterial cells and subsequent reaction with higher-potential oxidizing agents outside the cells, such as ferric iron and oxygen (). Acting as electron shuttles between bacteria and external substrates (), phenazines alleviate limitations posed by scarce electron acceptors (). Effectively, within the deep layers of the biofilm community, electrons accumulated for ATP synthesis can be accepted by oxidized phenazines and transferred to extracellular oxidants like oxygen. The cbb3-type terminal oxidases Cco1 and Cco2 of P. aeruginosa, key components of the respiratory chain, participate in phenazine reduction ().
Phenazines and the cellular redox state directly influence biofilm morphogenesis via the regulatory protein RmcA, which modulates matrix components responsible for wrinkle formation (; ). Phenazine-producing colonies tend to grow smoothly, whereas phenazine-deficient strains exhibit rougher, highly wrinkled biofilms that maximize oxygen contact (). Wrinkling serves as an adaptive mechanism to optimize oxygen accessibility and maintain metabolic homeostasis. Beyond their redox roles, phenazines act as signaling molecules that promote biofilm formation. P. aeruginosa synthesizes phenazine pigments such as pyocyanin, which intercalate into DNA base-pair regions, enhancing electron transfer, causing structural perturbations, and increasing DNA viscosity. The interaction is crucial for biofilm development (). Disrupting the pyocyanin—DNA interaction—via antioxidants or other inhibitors—can impede biofilm formation and associated infections (). The redox cycling of pyocyanin also generates reactive oxygen species (ROS), which damage host cells and pathogen cells, releasing eDNA (; ). Phenazine compounds also mediate efficient extracellular electron transfer (EET) by interacting with eDNA in P. aeruginosa biofilms (). Together with the anaerobic stress responses, phenazines promote antibiotic tolerance and contribute to disease progression (; ). Notably, phenazines enhance biofilm tolerance to antibiotics such as ciprofloxacin ().
Phenazines also stimulate pyruvate fermentation under anoxic conditions by mediating expression of the ackA and pta genes required for this pathway (). Through their redox cycling, phenazines enable P. aeruginosa to oxidize pyruvate to acetate and couple acetate metabolism with ATP synthesis via acetate kinase, thereby enhancing survival. In pyruvate fermentation, ATP generation is tightly linked to redox balance, a contrast to the arginine fermentation pathway where this connection is absent ().
3.3 Virulence expression
Mathematical modeling studies have demonstrated that bacterial biofilms growing anaerobically in anoxic environments secrete elevated levels of toxins. These toxins diffuse through the environment and lyse neutrophils, helping the biofilm resist neutrophil-mediated attacks. Consequently, bacterial adaptability and biofilm formation are enhanced under these conditions (). P. aeruginosa biofilms express a highly regulated protein secretion apparatus known as the type III secretion system (T3SS), which planktonic cells cannot deploy (). The T3SS directly translocates a specific subset of exotoxin effector proteins–including ExoS, ExoU, ExoT, and ExoY–into host cells, driving P. aeruginosa pathogenicity (; ). Multiple studies indicate that bacteria mount adaptive responses to diverse environments by modulating gene expression and protein production, thereby regulating the expression of virulence factors (; ) and inducing virulence protein synthesis (). Oxygen limitation is a critical regulator of T3SS expression, a major virulence determinant in P. aeruginosa. Exposure to hypoxic conditions activates the T3SS (; ). This activation strongly depends on the glyoxylate shunt enzyme isocitrate lyase (ICL, encoded by aceA), which is highly expressed in cystic fibrosis isolates specifically under oxygen-limited conditions (). ICL-dependent regulation influences the expression of the T3 structural proteins, effectors, and regulatory proteins (ExsC, ExsD, and ExsE). Additionally, aceA modulates biofilm formation by affecting the expression of pslA, a gene involved in the biosynthesis of an extracellular polysaccharide (). Notably, aceA mutants display enhanced biofilm formation during anaerobic growth.
The RetS/LadS signaling pathway reciprocally regulates T3SS expression and biofilm formation through a complex mechanism involving the GacS/GacA two-component system, the small regulatory RNAs RsmZ and RsmY, and the translational repressor RsmA (; ; ; ; ). Activation of LadS—or downregulation of RetS—promotes GacS homodimer formation, resulting in GacA phosphorylation and activation, accompanied by increased production of rsmZ and rsmY. These small RNAs sequester RsmA, relieving its repression and thereby activating biofilm formation (; ). Conversely, RetS activation induces heterodimer formation with GacS, inhibiting the GacS/GacA pathway. Free RsmA then binds specific mRNA targets, modulating their stability and indirectly activating exsA-dependent T3SS expression (). The regulation of AceA may be mediated by the RetS/LadS signaling pathway ().
Moreover, the anaerobic regulator Anr senses oxygen limitation and induces expression of narL within the NarL/NarX two-component system. NarL represses the RsmA-antagonistic RNAs rsmZ and rsmY, resulting in increased levels of free RsmA, which stimulates T3SS expression. Free RsmA positively regulates T3SS and possibly other virulence determinants under its control, serving as a convergence point for P. aeruginosa’s response to various environmental cues ().
Finally, P. aeruginosa OprG, an outer membrane protein belonging to the OmpW family of eight β-barrel porins, is broadly distributed. In iron-rich anaerobic environments, ANR significantly upregulates oprG transcription. Purified OprG forms cation-selective channels and substantially enhances cytotoxicity ().
4 Regulatory mechanisms under oxygen-limited conditions
P. aeruginosa biofilms adapt to oxygen-limited conditions through coordinated regulatory mechanisms. Anaerobic metabolism, including denitrification, arginine fermentation, and pyruvate fermentation, is activated under oxygen-limited conditions. Additionally, quorum sensing systems and the secondary messenger cyclic di-GMP (c-di-GMP) play crucial roles in modulating biofilm formation in response. Transcriptional regulatory networks involving the transcription factors ANR and DNR, and the NarXL two-component system, orchestrate the biofilm’s adaptive responses under oxygen-limited environments. Moreover, recent studies have also identified specific genes that further support biofilms growth and development under such conditions.
4.1 Anaerobic metabolism-related genes
4.1.1 Denitrification regulatory genes
The expression of narI and nirS genes in P. aeruginosa is upregulated under anaerobic conditions, playing key roles in anaerobic respiration (). Notably, P. aeruginosa may induce denitrification genes in response to low oxygen levels regardless of nitrate availability. During anaerobic growth, two nitrate reductase gene clusters are expressed, one encoding a membrane-bound enzyme complex (narGHJI) associated with the cytoplasmic membrane, and another encoding a periplasmic enzyme complex (napAB) (). The membrane-bound nitrate reductase is essential for anaerobic growth, as P. aeruginosa depends on it for energy generation when nitrate is present (). Enzymes involved in nitrate respiration, including nitrate reductases NapA and NarG, accumulate in biofilms (). Furthermore, antibodies against NapA and NarG have been detected in the serum of CF patients, confirming in vivo production of these respiratory enzymes by (). The periplasmic nitrate reductase is not essential for anaerobic energy generation. However, it may balance intracellular redox states under low oxygen, a role reported in other microorganisms (). It is plausible that P. aeruginosa utilizes the periplasmic nitrate reductase similarly. The Nar complex, located in the cytoplasmic membrane, drives proton-motive force generation and ATP synthesis, whereas the periplasmic Nap complex mainly balances intracellular redox states without contributing directly to the transmembrane electrochemical gradient (; ; ). This view contrasts with earlier findings where the periplasmic nitrate reductase and nitrate transport genes (e.g., narK2) were downregulated during anaerobic nitrate growth, with no observed differential regulation of the membrane-bound reductase (; ). The discrepancy may stem from methodological differences, as the prior study lacked saturating mutagenesis and thus might have missed mutants in the nar operon. The narG gene is critical for anaerobic growth across varying nitrate concentrations. The narG operon also includes two homologs of the nitrate/nitrite antiporter gene narK, as well as PA3871 (nifM) and moaA1, which encode molybdopterin cofactor synthesis enzymes, and narHJI, encoding additional subunits of the membrane-bound nitrate reductase ().
4.1.2 Arginine fermentation regulatory genes
The arc operon encodes three key enzymes in the ADI pathway, arcA (arginine deiminase), arcB (catabolic ornithine carbamoyltransferase), and arcC (carbamate kinase), which is induced under oxygen-limited conditions (). Subsequent studies revealed that the arc operon also includes the arcD, encoding a hydrophobic membrane-associated protein involved in the ADI process (). Proteomic analyses of hypoxic P. aeruginosa biofilm regions reveal increased proteins linked to L-arginine and polyamine metabolism, with elevated ArcA and ArcB indicating active arginine-based energy production. Concurrently, the abundance of the cytosolic aminopeptidase PepA is approximately threefold higher in hypoxic compared to aerobic regions. PepA likely contributes to cellular protein degradation, recycling amino acids for stress responses such as pH homeostasis and energy generation (). Furthermore, the DNA-binding protein HupB is eight times more abundant in hypoxic zones relative to aerobic zones (). HupB, a small histone-like protein also known as heat-unstable (HU) protein, protects DNA from oxidative damage and facilitates adaptation to stress (). In mammalian hosts, chronic P. aeruginosa infections are modulated by L-arginine metabolism and its derivative NO, with enhanced arginine catabolism observed at chronic wound sites (). Microaerobic environments typical of chronic infection sites favor L-arginine fermentation, leading to NO deficiency, a hallmark of diminished host defense (). Interestingly, L-arginine also supports phenazine production, and arginine metabolism remains largely unexplored ().
4.1.3 Pyruvate fermentation regulatory genes
A genome-wide analysis of anaerobic metabolism in P. aeruginosa identified several key pyruvate-metabolizing genes, including NADH-dependent lactate dehydrogenase (ldhA), phosphotransacetylase (pta), and acetate kinase (ackA) (). The conversion of pyruvate to lactate and acetate relies on the intact ldhA and ackA-pta gene clusters, respectively (). The anaerobic induction of the ackA-pta promoter is modulated by oxygen tension through the transcriptional regulators Anr and the integration host factor (IHF) (). IHF, potentially encoded by the anr gene, is believed to contain a 4Fe-4S cluster that functions as an oxygen tension sensor (; ; ). The ihfA locus encodes a subunit of the DNA-bending IHF protein, which plays a role in transcriptional regulation (, ). Additionally, the gacS-ldhA operon (PA0926 and PA0927) was identified, encoding the sensor kinase GacS of the GacA/GacS two-component regulatory system and a putative fermentative lactate dehydrogenase (LdhA), respectively (). The ackA-pta locus (PA0835 and PA0836) likely encodes acetate kinase and Pta, respectively, while the adhA locus (PA5427) encodes a putative alcohol dehydrogenase (AdhA) (). Under oxygen-limited conditions, adhA is induced to facilitate ethanol catabolism, contributing to anaerobic energy metabolism ().
4.2 Quorum sensing
P. aeruginosa utilizes quorum sensing (QS), a cell-density-dependent intercellular communication system, which plays a pivotal role in regulating bacterial virulence and biofilm formation (). Two principal QS signaling molecules, N-butyryl-L-homoserine lactone (C4-HSL) and N-(3-oxododecanoyl)-L-homoserine lactone (3O-C12-HSL), mediate QS through the transcriptional activator pairs lasR/lasI and rhlR/rhlI, respectively. Notably, the expression of lasI and rhlI is significantly upregulated under low oxygen conditions (). The QS system modulates genes involved in denitrification, thereby influencing bacterial growth and survival by regulating NO levels within the biofilm. Additionally, QS activates the transcription of the pel gene, partially through the Rhl system. The pel gene product synthesizes the glucose-rich extracellular polysaccharide matrix essential for P. aeruginosa biofilm formation (; ).
In the CF airway environment, optimal expression of the rhl QS component benefits P. aeruginosa persistence. QS controls the expression of the snr-1 gene, which in turn regulates the denitrification rate (). Specifically, the rhl system acts as an anaerobic repressor of snr-1 transcription. Consequently, in the absence of RhlR, the reducing power provided by Snr-1 increases, thus enhancing NAR activity. However, dysregulation of denitrification genes in rhlR mutants leads to elevated transcription of nar and nir genes, causing accumulation of toxic NO and subsequent self-damage (). NO, a by-product of anaerobic respiration, accumulates in rhlR mutants despite a modest increase (2-fold) in NOR activity, which is insufficient to mitigate NO toxicity (). Thus, under anaerobic conditions, P. aeruginosa relies on the rhl QS system and NO reductase to regulate NO levels and sustain robust biofilm formation and survival ().
4.3 3,5-cyclic diguanylic acid (c-di-GMP)
Another crucial signaling molecule in P. aeruginosa is the second messenger 3,5-cyclic diguanylic acid (c-di-GMP), which facilitates bacterial adaptation to diverse environmental conditions (; ). The c-di-GMP plays a central role in regulating biofilm formation and dispersion (). Elevated intracellular c-di-GMP levels drive the transition from a planktonic to a biofilm lifestyle by repressing motility-related genes, including those regulated by FleQ, and activating genes involved in exopolysaccharide production and biofilm maturation (). Conversely, reduced c-di-GMP levels trigger biofilm dispersion by activating motility structures, including flagella and pili (). The synthesis and degradation of c-di-GMP are catalyzed by diguanylate cyclases (DGCs) and phosphodiesterases (PDEs), respectively (). Although the interplay between QS and c-di-GMP signaling in P. aeruginosa is not fully elucidated, both pathways regulate virulence and biofilm dynamics, suggesting potential crosstalk. Current evidence indicates that the QS system can modulate intracellular c-di-GMP concentrations (). Specifically, the Las-QS system may elevate c-di-GMP levels by stimulating DGC activity, whereas the Rhl-QS system might decrease c-di-GMP by inducing PDE activity. Furthermore, the tyrosine phosphatase TpbA inhibits the activity of the DGC TpbB via dephosphorylation, thereby reducing biofilm formation. Las-QS positively regulates TpbA expression, while Rhl-QS does not influence it (). Interestingly, TpbA also enhances rhl transcription, indicating that QS can negatively regulate c-di-GMP production in P. aeruginosa. However, the exact dynamics of c-di-GMP synthesis under varying QS states remain unclear. Moreover, NO has been reported to modulate DGC and PDE activities (; ). NO inhibits biofilm formation by enhancing PDE activity, leading to decreased intracellular c-di-GMP levels ().
4.4 Transcription factors
TFs play a crucial role in regulating gene expression in response to environmental changes. Bacteria sense oxygen-limited conditions in their environment through Anr or Dnr, and regulate the expression of a series of genes to enable the bacteria to colonize and grow in oxygen-limited environments.
4.4.1 Anr
Anr is a well-characterized global transcriptional regulator and a key activator of gene expression under hypoxic conditions. It governs a regulatory network of hypoxia-responsive genes and serves as a hallmark of anaerobic or microaerobic growth (). Under low oxygen tension, active Anr promotes P. aeruginosa biofilm formation and virulence, playing a crucial role in host colonization (; ). Deletion of the anr gene results in defective biofilm development and often abolishes anaerobic growth, whereas elevated Anr activity enhances biofilm formation (). Nevertheless, the precise underlying mechanisms remain incompletely understood. Notably, Anr regulon genes show no significant transcriptional increase under hypoxia, consistent with the findings of Alvarez-Orgeta et al (), suggesting Anr regulation involves mechanisms beyond its own regulon transcription.
Anr is indispensable for activating energy metabolism pathways during hypoxia. It strongly induces denitrification and regulates the expression of other transcriptional regulators, including dnr and the narXL two-component system (). The dnr is essential for activating denitrification during anaerobic growth, controlling a subset of genes involved in nitrate respiration (). The NarL response regulator modulates energy metabolism under hypoxic stress by promoting nitrate utilization and repressing less efficient energy-yielding pathways such as pyruvate and arginine fermentation (; ). Interestingly, while Anr enhances NarL production, it also independently promotes arginine fermentation by upregulating the arcDABC operon under anaerobic conditions (). Furthermore, Anr activates the ackA-pta operon responsible for pyruvate fermentation in response to low oxygen (; ).
Anr also upregulates genes encoding high-affinity cytochrome oxidases (hemF and hemN) and CupA fimbriae components (oprG and cupA1-5), facilitating respiratory adaptation during hypoxia and contributing to biofilm development and pathogenicity (). Additionally, Anr influences quorum sensing by regulating the small regulatory RNA PhrS (), thereby modulating biofilm adaptability under low oxygen.
A well-studied virulence factor of P. aeruginosa, the hemolytic phospholipase C (PlcH), is tightly regulated by Anr. The catabolism of choline released by PlcH enhances Anr activity (; , ). The plcH promoter contains a conserved Anr consensus binding sequence across all P. aeruginosa genomes (; ). Anr represses plcH expression, maintaining PlcH protein at levels that facilitate effective host-pathogen interactions without compromising biofilm integrity (). Under oxygen-limited conditions, PlcH production may become disadvantageous, as excessive PlcH protein can compromise the structural integrity of the P. aeruginosa biofilm. Anr likely binds directly to the plcH promoter, which contains a conserved Anr consensus sequence across all P. aeruginosa genomes. Mutations in this conserved sequence result in increased plcH expression under hypoxia. Although Anr shares its consensus binding sequence with the secondary regulator Dnr, their activation mechanisms differ; notably, Dnr does not participate in plcH repression (). Anr is active when its 4Fe-4S iron-sulfur cluster remains intact, whereas Dnr is activated by the oxidation of its heme cofactor by nitric oxide, which induces a conformational change enabling DNA binding (; ).
The small RNA ErsA also plays an important role in anaerobic adaptation. It regulates bacterial-host interactions, including biofilm maturation, motility, and antibiotic resistance (; Zhang et al., 2017; ). ErsA is transcriptionally induced under oxygen-limited conditions () and transmits low-oxygen signals to the Anr regulon. It positively regulates Anr expression at the post-transcriptional level (). Once ErsA surpasses a certain threshold, the RNA-binding protein Hfq acts synergistically with ErsA to activate Anr. This function of Hfq complements its own post-transcriptional regulation of Anr, indicating that ErsA-mediated activation of anr expression depends on Hfq (). Hfq’s chaperone activity likely promotes the interaction between ErsA and anr mRNA, enhancing anr mRNA translation, possibly by improving access to its initiation site. This positive regulation by ErsA contributes to the stabilization of anr mRNA, consistent with the observed reduction in anr mRNA levels when ErsA is absent. Additionally, Hfq has been reported to stimulate anr expression via an unknown mechanism (; ). Deletion of ErsA leads to reduced virulence of P. aeruginosa both in vitro and in vivo, markedly impaired biofilm formation and maturation (), and severely compromised anaerobic growth through denitrification and arginine fermentation. The role of ErsA in biofilm regulation may also involve downregulation of the AlgC enzyme () and the activation of the AmrZ regulon (). Furthermore, ErsA directly negatively regulates oprD mRNA, affecting the envelope composition of P. aeruginosa (Zhang et al., 2017; ). These findings suggest that P. aeruginosa’s adaptation to the CF lung environment may increase its reliance on ErsA for regulating anaerobic metabolism.
4.4.2 DNR
DNR is a critical transcriptional activator essential for initiating the denitrification process in P. aeruginosa. It was the first protein identified to restore anaerobic respiration and arginine substrate-level phosphorylation growth in anr mutants (). The expression and activity of Dnr are themselves regulated by Anr, positioning Dnr downstream in the oxygen-sensing regulatory cascade. Under hypoxic conditions, both Anr and Dnr coordinate to activate transcription of genes involved in denitrification and anaerobic respiration. Key operons under their control include narKGHJIm, encoding nitrate reductase; nirSM-CFLGHJEN, encoding nitrite reductase; and ccoN2O2Q2P2, encoding the cbb3–2 cytochrome oxidase complex.
In the presence of nitrate under anaerobic conditions, expression from the narK1 promoter is induced through the combined action of Anr, Dnr, and the nitrate-responsive two-component regulatory system NarXL (). The DNA-bending protein integration host factor (IHF) is also crucial for optimal promoter activity. Moreover, Anr and NarXL induce dnr expression, amplifying the regulatory cascade (). The cooperative function of NarXL and Dnr, regulated by ANR, is necessary for transcription of the nitrite reductase regulatory gene nirQ under anaerobic conditions (; ). Dnr belongs to the Crp-Fnr superfamily of transcriptional regulators and has been reported to activate expression of genes involved in the denitrification pathway, including nir, nor, and nos (; ). Transcriptional control of the nar locus occurs via the intergenic region between narXL and narK1. Both nitrate and nitrite induce narK expression, and a basal induction persists even during arginine fermentation (). The narK1 promoter activity is modulated by both Anr and Dnr, with Anr being indispensable for its baseline activation, while Dnr enhances promoter activity independently of Anr (). Anr indirectly facilitates transcriptional activation of nirS by inducing dnr expression in this regulatory hierarchy. The transcription of NorC also requires Anr and Dnr in the presence of nitrous oxide but is not directly regulated by NarL ().
Although the small RNA ErsA positively regulates Anr post-transcriptional (), no direct regulation of Dnr by ErsA has been observed. Nevertheless, dnr transcript levels decrease in the absence of ErsA, likely due to diminished Anr expression. Additionally, under anaerobic conditions, expression of the narXL genes is also upregulated by both Anr and Dnr ().
4.5 Two-component regulatory system
Two-component systems (TCSs) are widespread in prokaryotic genomes and constitute a fundamental regulatory network that enables bacteria to adapt, survive, and modulate pathogenicity in response to environmental changes. Functioning as molecular switches, these systems sense external stimuli and regulate gene expression accordingly, facilitating bacterial adaptation to diverse conditions. A canonical TCS consists of a membrane-bound sensor kinase (SK) and a cytoplasmic response regulator (RR), typically encoded adjacently in the genome (). Upon sensing environmental signals, the sensor domain of the SK undergoes conformational changes that are transmitted through the transmembrane region to its cytoplasmic histidine kinase domain. This triggers autophosphorylation of a conserved C-terminal histidine residue in trans (; ). The phosphoryl group is then transferred to a conserved aspartate residue on the RR, activating it. The activated RR modulates the transcription of downstream genes involved in diverse physiological processes, including bacterial virulence, pathogenesis, biofilm formation, cell division, and metabolite production (; ).
In P. aeruginosa, the NarXL system is a nitrate-responsive two-component regulatory system (). NarX is the sensor kinase and NarL its response regulator; in the presence of nitrate, NarXL activates and cooperates with Dnr to upregulate nar, nir, and nor genes encoding nitrate, nitrite, and nitric oxide reductases (). Simultaneously, NarL represses the arginine fermentation pathway by inhibiting the arginine-dependent activation of the arcDABC operon mediated by the transcriptional activator ArgR. Specifically, NarL suppresses the expression of arcA, arcB, and arcC genes without affecting the oxygen tension-dependent activation driven by Anr (). Under conditions where both nitrate and arginine are present, NarL binding likely interferes with ArgR’s interaction at overlapping DNA binding sites, thereby preventing ArgR-mediated induction of arcDABC transcription ().
4.6 Other factors
In addition to above factors, studies have identified other specialized genes that promote P. aeruginosa growth and biofilm formation. OmpW is an eight-helix β-barrel outer membrane porin that facilitates the uptake of small hydrophobic molecules (). It has been demonstrated that OmpW participates in bacterial adaptation to various environmental stresses (). In P. aeruginosa, OmpW expression is upregulated under hypoxic or anaerobic conditions (). However, OmpW expression may be downregulated when iron levels are low, as OmpW is implicated in iron uptake (). Concurrently, under hypoxia, the global regulator Lrp is upregulated (). The ompW promoter contains an Lrp-binding site, through which Lrp negatively regulates ompW expression ().
Another crucial outer membrane protein, OprF, functions as a cytokine and plays a vital role in regulating anaerobic metabolism in P. aeruginosa. It is essential for the optimal survival of anaerobic biofilms (). The absence of OprF results in severely impaired bacterial growth due to the loss of nitrite reductase activity and defects in anaerobic respiration. Notably, OprF is detectable exclusively in anaerobic biofilms (), and only CF patients with chronic infections possess antibodies against OprF. Bacteria lacking oprF exhibit diminished anaerobic biofilm formation, partly attributable to the lack of NIR activity. Two hypotheses have been proposed regarding OprF’s precise role in anaerobic growth. First, OprF may serve as a porin facilitating nitrate or nitrite transport into the cell and potentially interact directly with NIR to stabilize its enzymatic activity. Second, the absence of OprF may compromise peptidoglycan stability, as OprF has been shown to interact with this essential cell wall component (). Reduced peptidoglycan integrity renders cells more fragile and susceptible to environmental stress.
5 Clinical significance and future directions
Biofilm formation serves as a crucial protective strategy, enabling pathogenic bacteria to resist various environmental stresses (). The hypoxic microenvironment within biofilms facilitates bacterial adaptation through reduced metabolic activity and heightened antibiotic tolerance (; ), which contributes to persistent chronic infections. Traditional antibacterial treatments have largely targeted the eradication of pathogens but often overlook the modulation of the infected microenvironment, resulting in issues such as antibiotic resistance and incomplete bacterial clearance (; Zhao et al., 2023b). Recently, strategies aimed at reversing the hypoxic microenvironment have emerged as a promising research focus for combating biofilm-associated infections.
Reversal of hypoxia triggers a cascade of beneficial effects, including the reactivation of suppressed immune responses, promotion of osteogenesis and angiogenesis, induction of cuproptosis-like bacterial death, and stimulation of dendritic cells and macrophages to enhance antibacterial activity via chemotaxis and phagocytosis (). Photodynamic therapy (PDT) is a notable antibacterial approach capable of effectively killing bacteria and preventing multidrug resistance; however, its efficacy is markedly compromised under hypoxic conditions. Enhancing oxygen delivery to treatment sites and alleviating hypoxia significantly improves PDT efficacy, providing a promising avenue for biofilm eradication (; ; ).
Recent advancements include the development of porphyrinic metal-organic framework (MOF)-based metalloantibiotics that catalyze endogenous hydrogen peroxide (H2O2) decomposition to generate oxygen. The resulting oxygen enhances oxygen-dependent sonodynamic therapy (SDT), which disrupts bacterial homeostasis—affecting cell membrane integrity and quorum sensing systems—thereby promoting bacterial killing (). Concurrently, sustained oxygen production supports fibroblast survival and migration, stimulates angiogenic growth factors, promotes angiogenesis, and increases secretion of anti-inflammatory cytokines (). Nitric oxide (NO) exhibits dual effects depending on its concentration: high levels possess bactericidal activity, whereas low levels induce biofilm dispersion and sensitize bacteria to antibiotics (). In P. aeruginosa models, low-dose NO, which is non-lethal, acts as a signaling molecule triggering biofilm dispersal in ex vivo cystic fibrosis (CF) sputum, reducing bacterial tolerance to tobramycin alone or combined with ceftazidime. This highlights NO’s potential as an adjunct therapy for managing P. aeruginosa biofilm infections in CF patients (). Consequently, NO-based treatments represent a promising approach against antibiotic-resistant bacteria and biofilm-associated infections. Overall, alleviating biofilm hypoxia holds significant potential for enhancing treatment efficacy and overcoming chronic biofilm-related infections.
6 Conclusions
Biofilm cells exhibit an oxygen gradient that typically reduces their sensitivity to antibiotics, making complete eradication challenging. The adaptation of bacterial biofilms to hypoxic conditions is considered a crucial factor for their prolonged latent persistence in the human body. This hypoxic microenvironment triggers a series of complex bacterial responses. Current studies suggest that under oxygen-limited conditions, P. aeruginosa shifts to anaerobic metabolism, utilizing nitrate for denitrification to support growth. In the absence of nitrate or nitrite, survival is maintained through arginine or pyruvate fermentation pathways. Additionally, P. aeruginosa biofilms produce phenazine compounds to sustain redox balance within the biofilm matrix. Adaptation to oxygen limitation also involves the regulation of virulence gene expression and QS systems. These processes are coordinately controlled by transcriptional regulators such as Anr, Dnr, NarXL, and other specialized genes, collectively promoting bacterial survival and biofilm formation. A deeper understanding of the adaptive mechanisms employed by bacterial biofilms under oxygen-limited conditions can provide new directions for future treatments of biofilm-associated infections, including strategies targeting QS or c-di-GMP pathways, modulation of Anr or Dnr regulators, and nitric oxide-based therapies.
Statements
Author contributions
LR: Writing – review & editing, Writing – original draft. YY: Writing – original draft, Writing – review & editing. KF: Writing – review & editing, Data curation, Investigation. XF: Investigation, Data curation, Writing – review & editing. JH: Writing – review & editing, Visualization. BZ: Conceptualization, Writing – review & editing. YL: Supervision, Writing – review & editing.
Funding
The author(s) declare financial support was received for the research and/or publication of this article. This work was supported by Basic Scientific Research Project of Education Department of Liaoning Province (LJKMZ20221190).
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Generative AI statement
The author(s) declare that no Generative AI was used in the creation of this manuscript.
Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
References
1
Alvarez-OrtegaC.HarwoodC. S. (2007a). Identification of a malate chemoreceptor in pseudomonas aeruginosa by screening for chemotaxis defects in an energy taxis-deficient mutant. Appl. Environ. Microbiol.73, 7793–7795. doi: 10.1128/AEM.01898-07
2
Alvarez-OrtegaC.HarwoodC. S. (2007b). Responses of Pseudomonas aeruginosa to low oxygen indicate that growth in the cystic fibrosis lung is by aerobic respiration. Mol. Microbiol.65, 153–165. doi: 10.1111/j.1365-2958.2007.05772.x
3
AraiH.IgarashiY.KodamaT. (1995). Expression of the nir and nor genes for denitrification of pseudomonas aeruginosa requires a novel CRP/FNR-related transcriptional regulator, DNR, in addition to ANR. FEBS Lett.371, 73–76. doi: 10.1016/0014-5793(95)00885-d
4
AraiH.MizutaniM.IgarashiY. (2003). Transcriptional regulation of the nos genes for nitrous oxide reductase in pseudomonas aeruginosa. Microbiol. (read. Engl.)149, 29–36. doi: 10.1099/mic.0.25936-0
5
AristotelousA. C. (2022). Biofilm neutrophils interactions under hypoxia: A mathematical modeling study. Math Biosci.352, 108893. doi:Â 10.1016/j.mbs.2022.108893
6
BaiY.HuY.GaoY.WeiX.LiJ.ZhangY.et al. (2021). Oxygen self-supplying nanotherapeutic for mitigation of tissue hypoxia and enhanced photodynamic therapy of bacterial keratitis. ACS Appl. Mater Interfaces13, 33790–33801. doi: 10.1021/acsami.1c04996
7
BalasubramanianD.HarperL.ShopsinB.TorresV. J. (2017). Staphylococcus aureus pathogenesis in diverse host environments. Pathog. Dis.75, ftx005. doi:Â 10.1093/femspd/ftx005
8
BaraquetC.HarwoodC. S. (2013). Cyclic diguanosine monophosphate represses bacterial flagella synthesis by interacting with the Walker A motif of the enhancer-binding protein FleQ. Proc. Natl. Acad. Sci. U.S.A.110, 18478–18483. doi: 10.1073/pnas.1318972110
9
BegA. Z.RashidF.TalatA.HaseenM. A.RazaN.AkhtarK.et al. (2023). Functional amyloids in pseudomonas aeruginosa are essential for the proteome modulation that leads to pathoadaptation in pulmonary niches. Microbiol. Spectr.11, e0307122. doi:Â 10.1128/spectrum.03071-22
10
BenkertB.QuäckN.SchreiberK.JaenschL.JahnD.SchobertM. (2008). Nitrate-responsive NarX-NarL represses arginine-mediated induction of the Pseudomonas aeruginosa arginine fermentation arcDABC operon. Microbiol. (Reading)154, 3053–3060. doi: 10.1099/mic.0.2008/018929-0
11
Borrero-de AcuñaJ. M.MolinariG.RohdeM.DammeyerT.WissingJ.JänschL.et al. (2015). A periplasmic complex of the nitrite reductase NirS, the chaperone DnaK, and the flagellum protein FliC is essential for flagellum assembly and motility in pseudomonas aeruginosa. J. Bacteriol.197, 3066–3075. doi: 10.1128/JB.00415-15
12
Borrero-de AcuñaJ. M.RohdeM.WissingJ.JänschL.SchobertM.MolinariG.et al. (2016). Protein network of the pseudomonas aeruginosa denitrification apparatus. J. Bacteriol.198, 1401–1413. doi: 10.1128/JB.00055-16
13
BorrielloG.WernerE.RoeF.KimA. M.EhrlichG. D.StewartP. S. (2004). Oxygen limitation contributes to antibiotic tolerance of Pseudomonas aeruginosa in biofilms. Antimicrobial Agents chemotherapy.48, 2659–2664. doi: 10.1128/AAC.48.7.2659-2664.2004
14
BrambillaL.Morán-BarrioJ.VialeA. M. (2014). Expression of the Escherichia coli ompW colicin S4 receptor gene is regulated by temperature and modulated by the H-NS and StpA nucleoid-associated proteins. FEMS Microbiol. Lett.352, 238–244. doi: 10.1111/1574-6968.12385
15
BrencicA.McFarlandK. A.McManusH. R.CastangS.MognoI.DoveS. L.et al. (2009). The GacS/GacA signal transduction system of pseudomonas aeruginosa acts exclusively through its control over the transcription of the RsmY and RsmZ regulatory small RNAs. Mol. Microbiol.73, 434–445. doi: 10.1111/j.1365-2958.2009.06782.x
16
CaiY. M.ZhangY. D.YangL. (2021). NO donors and NO delivery methods for controlling biofilms in chronic lung infections. Appl. Microbiol. Biotechnol.105, 3931–3954. doi: 10.1007/s00253-021-11274-2
17
CarreauA.El Hafny-RahbiB.MatejukA.GrillonC.KiedaC. (2011). Why is the partial oxygen pressure of human tissues a crucial parameter? Small molecules and hypoxia. J. Cell Mol. Med.15, 1239–1253. doi: 10.1111/j.1582-4934.2011.01258.x
18
Catel-FerreiraM.MartiS.GuillonL.JaraL.CoadouG.MolleV.et al. (2016). The outer membrane porin OmpW of Acinetobacter baumannii is involved in iron uptake and colistin binding. FEBS Lett.590, 224–231. doi: 10.1002/1873-3468.12050
19
ChenF.XiaQ.JuL.-K. (2006). Competition between oxygen and nitrate respirations in continuous culture of pseudomonas aeruginosa performing aerobic denitrification. Biotechnol. Bioeng.93, 1069–1078. doi: 10.1002/bit.20812
20
ChibaA.SekiM.SuzukiY.KinjoY.MizunoeY.SugimotoS. (2022). Staphylococcus aureus utilizes environmental RNA as a building material in specific polysaccharide-dependent biofilms. NPJ Biofilms Microbiomes8, 17. doi:Â 10.1038/s41522-022-00278-z
21
ChungJ. C. S.RzhepishevskaO.RamstedtM.WelchM. (2013). Type III secretion system expression in oxygen-limited Pseudomonas aeruginosa cultures is stimulated by isocitrate lyase activity. Open Biol.3, 120131. doi:Â 10.1098/rsob.120131
22
CiemnieckiJ. A.NewmanD. K. (2020). The potential for redox-active metabolites to enhance or unlock anaerobic survival metabolisms in aerobes. J. Bacteriol202, e00797–e00719. doi: 10.1128/JB.00797-19
23
CiofuO.Tolker-NielsenT. (2019). Tolerance and Resistance of Pseudomonas aeruginosa Biofilms to Antimicrobial Agents-How P. aeruginosa Can Escape Antibiotics. Front. Microbiol.10. doi:Â 10.3389/fmicb.2019.00913
24
CowellB. A.EvansD. J.FleiszigS. M. J. (2005). Actin cytoskeleton disruption by ExoY and its effects on Pseudomonas aeruginosa invasion. FEMS Microbiol. Lett.250, 71–76. doi: 10.1016/j.femsle.2005.06.044
25
CowleyE. S.KopfS. H.LaRiviereA.ZiebisW.NewmanD. K. (2015). Pediatric cystic fibrosis sputum can be chemically dynamic, anoxic, and extremely reduced due to hydrogen sulfide formation. mBio6, e00767. doi:Â 10.1128/mBio.00767-15
26
CrabbéA.JensenP.Ø.BjarnsholtT.CoenyeT. (2019). Antimicrobial tolerance and metabolic adaptations in microbial biofilms. Trends Microbiol.27, 850–863. doi: 10.1016/j.tim.2019.05.003
27
CrockerA. W.HartyC. E.HammondJ. H.WillgerS. D.SalazarP.BotelhoN. J.et al. (2019). Pseudomonas aeruginosa ethanol oxidation by AdhA in low-oxygen environments. J. Bacteriol.201, e00393–e00319. doi: 10.1128/JB.00393-19
28
CullenL.McCleanS. (2015). Bacterial adaptation during chronic respiratory infections. Pathogens4, 66–89. doi: 10.3390/pathogens4010066
29
Cutruzzolà F.Frankenberg-DinkelN. (2016). Origin and impact of nitric oxide in Pseudomonas aeruginosa biofilms. J. Bacteriol198, 55–65. doi: 10.1128/JB.00371-15
30
DasT.KuttyS. K.TavallaieR.IbugoA. I.PanchompooJ.SeharS.et al. (2015). Phenazine virulence factor binding to extracellular DNA is important for Pseudomonas aeruginosa biofilm formation. Sci. Rep.5, 8398. doi:Â 10.1038/srep08398
31
DasT.ManefieldM. (2012). Pyocyanin promotes extracellular DNA release in pseudomonas aeruginosa. PLoS One7, e46718. doi:Â 10.1371/journal.pone.0046718
32
DebatsI. B. J. G.BooiD.DeutzN. E. P.BuurmanW. A.BoeckxW. D.van der HulstR. R. W. J. (2006). Infected chronic wounds show different local and systemic arginine conversion compared with acute wounds. J. Surg. Res.134, 205–214. doi: 10.1016/j.jss.2006.03.005
33
Delic-AttreeI.ToussaintB.FrogerA.WillisonJ. C.VignaisP. M. (1996). Isolation of an IHF-deficient mutant of a pseudomonas aeruginosa mucoid isolate and evaluation of the role of IHF in algD gene expression. Microbiol. (read. Engl.)142, 2785–2793. doi: 10.1099/13500872-142-10-2785
34
Delic-AttreeI.ToussaintB.VignaisP. M. (1995). Cloning and sequence analyses of the genes coding for the integration host factor (IHF) and HU proteins of pseudomonas aeruginosa. Gene154, 61–64. doi: 10.1016/0378-1119(94)00875-s
35
DietrichL. E. P.OkegbeC.Price-WhelanA.SakhtahH.HunterR. C.NewmanD. K. (2013). Bacterial community morphogenesis is intimately linked to the intracellular redox state. J. Bacteriol195, 1371–1380. doi: 10.1128/JB.02273-12
36
DietrichL. E. P.TealT. K.Price-WhelanA.NewmanD. K. (2008). Redox-active antibiotics control gene expression and community behavior in divergent bacteria. Sci. (n. Y. N.Y.)321, 1203–1206. doi: 10.1126/science.1160619
37
DonlanR. M. (2002). Biofilms: microbial life on surfaces. Emerg. Infect. Dis.8, 881–890. doi: 10.3201/eid0809.020063
38
EhrhardtK.BeckerA. L.GrasslG. A. (2023). Determinants of persistent Salmonella infections. Curr. Opin. Immunol.82, 102306. doi:Â 10.1016/j.coi.2023.102306
39
EschbachM.SchreiberK.TrunkK.BuerJ.JahnD.SchobertM. (2004). Long-term anaerobic survival of the opportunistic pathogen Pseudomonas aeruginosa via pyruvate fermentation. J. Bacteriol186, 4596–4604. doi: 10.1128/JB.186.14.4596-4604.2004
40
FalconeM.FerraraS.RossiE.JohansenH. K.MolinS.BertoniG. (2018). The small RNA ErsA of pseudomonas aeruginosa contributes to biofilm development and motility through post-transcriptional modulation of AmrZ. Front. Microbiol.9. doi:Â 10.3389/fmicb.2018.00238
41
FangF. C. (1997). Perspectives series: host/pathogen interactions. Mechanisms of nitric oxide-related antimicrobial activity. J. Clin. Invest.99, 2818–2825. doi: 10.1172/JCI119473
42
FangF. C.FrawleyE. R.TapscottT.Vázquez-TorresA. (2016). Bacterial stress responses during host infection. Cell Host Microbe20, 133–143. doi: 10.1016/j.chom.2016.07.009
43
FerraraS.CarloniS.FulcoR.FalconeM.MacchiR.BertoniG. (2015). Post-transcriptional regulation of the virulence-associated enzyme AlgC by the σ22-dependent small RNA ErsA of Pseudomonas aeruginosa. Environ. Microbiol.17, 199–214. doi: 10.1111/1462-2920.12590
44
FerraraS.CarrubbaR.SantoroS.BertoniG. (2021). The small RNA ErsA impacts the anaerobic metabolism of Pseudomonas aeruginosa through post-transcriptional modulation of the master regulator anr. Front. Microbiol.12. doi:Â 10.3389/fmicb.2021.691608
45
FerraraS.RossiA.RanucciS.De FinoI.BragonziA.CiganaC.et al. (2020). The small RNA ErsA plays a role in the regulatory network of pseudomonas aeruginosa pathogenicity in airway infections. Msphere5, e00909-20. doi:Â 10.1128/msphere.00909-20
46
FerreiraM. T.MansoA. S.GasparP.PinhoM. G.NevesA. R. (2013). Effect of oxygen on glucose metabolism: utilization of lactate in Staphylococcus aureus as revealed by in vivo NMR studies. PLoS One8, e58277. doi:Â 10.1371/journal.pone.0058277
47
FiliatraultM. J.PicardoK. F.NgaiH.PassadorL.IglewskiB. H. (2006). Identification of Pseudomonas aeruginosa genes involved in virulence and anaerobic growth. Infect. Immun.74, 4237–4245. doi: 10.1128/IAI.02014-05
48
FiliatraultM. J.WagnerV. E.BushnellD.HaidarisC. G.IglewskiB. H.PassadorL. (2005). Effect of anaerobiosis and nitrate on gene expression in pseudomonas aeruginosa. Infect. Immun.73, 3764–3772. doi: 10.1128/IAI.73.6.3764-3772.2005
49
FriedmanL.KolterR. (2004). Genes involved in matrix formation in pseudomonas aeruginosa PA14 biofilms. Mol. Microbiol.51, 675–690. doi: 10.1046/j.1365-2958.2003.03877.x
50
GaleM. J.MaritatoM. S.ChenY.-L.AbdulateefS. S.RuizJ. E. (2015). Pseudomonas aeruginosa causing inflammatory mass of the nasopharynx in an immunocompromised HIV infected patient: a mimic of Malignancy. Idcases2, 40–43. doi: 10.1016/j.idcr.2015.01.004
51
GalimandM.GamperM.ZimmermannA.HaasD. (1991). Positive FNR-like control of anaerobic arginine degradation and nitrate respiration in pseudomonas aeruginosa. J. Bacteriol.173, 1598–1606. doi: 10.1128/jb.173.5.1598-1606.1991
52
GardnerA. M.GessnerC. R.GardnerP. R. (2003). Regulation of the nitric oxide reduction operon (norRVW) in Escherichia coli. Role of NorR and sigma54 in the nitric oxide stress response. J. Biol. Chem.278, 10081–10086. doi: 10.1074/jbc.M212462200
53
Gil-MarquésM. L.PachónJ.SmaniY. (2022). iTRAQ-Based Quantitative Proteomic Analysis of Acinetobacter baumannii under Hypoxia and Normoxia Reveals the Role of OmpW as a Virulence Factor. Microbiol. Spectr.10, e0232821. doi: 10.1128/spectrum.02328-21
54
GlasserN. R.KernS. E.NewmanD. K. (2014). Phenazine redox cycling enhances anaerobic survival in Pseudomonas aeruginosa by facilitating generation of ATP and a proton-motive force. Mol. Microbiol.92, 399–412. doi: 10.1111/mmi.12566
55
GlasserN. R.SaundersS. H.NewmanD. K. (2017). The colorful world of extracellular electron shuttles. Annu. Rev. Microbiol.71, 731–751. doi: 10.1146/annurev-micro-090816-093913
56
GomilaA.Carratalà J.BadiaJ. M.CamprubÃD.PirizM.ShawE.et al. (2018). Preoperative oral antibiotic prophylaxis reduces Pseudomonas aeruginosa surgical site infections after elective colorectal surgery: a multicenter prospective cohort study. BMC Infect. Dis.18, 507. doi: 10.1186/s12879-018-3413-1
57
GoodmanA. L.KulasekaraB.RietschA.BoydD.SmithR. S.LoryS. (2004). A signaling network reciprocally regulates genes associated with acute infection and chronic persistence in pseudomonas aeruginosa. Dev. Cell7, 745–754. doi: 10.1016/j.devcel.2004.08.020
58
GoodmanA. L.MerighiM.HyodoM.VentreI.FillouxA.LoryS. (2009). Direct interaction between sensor kinase proteins mediates acute and chronic disease phenotypes in a bacterial pathogen. Genes Dev.23, 249–259. doi: 10.1101/gad.1739009
59
GrasemannH.RatjenF. (2012). Nitric oxide and L-arginine deficiency in cystic fibrosis. Curr. Pharm. Des.18, 726–736. doi: 10.2174/138161212799315911
60
GreenJ.ScottC.GuestJ. R. (2001). Functional versatility in the CRP-FNR superfamily of transcription factors: FNR and FLP. Adv. Microb. Physiol.44, 1–34. doi: 10.1016/s0065-2911(01)44010-0
61
HaD.-G.MerrittJ. H.HamptonT. H.HodgkinsonJ. T.JanecekM.SpringD. R.et al. (2011). 2-Heptyl-4-quinolone, a precursor of the Pseudomonas quinolone signal molecule, modulates swarming motility in Pseudomonas aeruginosa. J. Bacteriol193, 6770–6780. doi: 10.1128/JB.05929-11
62
HaD.-G.O’TooleG. A. (2015). c-di-GMP and its effects on biofilm formation and dispersion: a Pseudomonas aeruginosa review. Microbiol. Spectr.3, MB–0003-2014. doi: 10.1128/microbiolspec.MB-0003-2014
63
Hall-StoodleyL.McCoyK. S. (2022). Biofilm aggregates and the host airway-microbial interface. Front. Cell Infect. Microbiol.12. doi:Â 10.3389/fcimb.2022.969326
64
HammondJ. H.DolbenE. F.SmithT. J.BhujuS.HoganD. A. (2015). Links between Anr and Quorum sensing in Pseudomonas aeruginosa biofilms. J. Bacteriol197, 2810–2820. doi: 10.1128/JB.00182-15
65
HasegawaN.AraiH.IgarashiY. (1998). Activation of a consensus FNR-dependent promoter by DNR of pseudomonas aeruginosa in response to nitrite. FEMS Microbiol. Lett.166, 213–217. doi: 10.1111/j.1574-6968.1998.tb13892.x
66
HassettD. J.CuppolettiJ.TrapnellB.LymarS. V.RoweJ. J.YoonS. S.et al. (2002). Anaerobic metabolism and quorum sensing by Pseudomonas aeruginosa biofilms in chronically infected cystic fibrosis airways: rethinking antibiotic treatment strategies and drug targets. Adv. Drug Delivery Rev.54, 1425–1443. doi: 10.1016/s0169-409x(02)00152-7
67
HassettD. J.SuttonM. D.SchurrM. J.HerrA. B.CaldwellC. C.MatuJ. O. (2009). Pseudomonas aeruginosa hypoxic or anaerobic biofilm infections within cystic fibrosis airways. Trends Microbiol.17, 130–138. doi: 10.1016/j.tim.2008.12.003
68
HøibyN.MoserC.CiofuO. (2024). Pseudomonas aeruginosa in the frontline of the greatest challenge of biofilm infection-its tolerance to antibiotics. Microorganisms12, 2115. doi: 10.3390/microorganisms12112115
69
HouS.MahadevegowdaS. H.LuD.ZhangK.Chan-ParkM. B.DuanH. (2021). Metabolic labeling mediated targeting and thermal killing of gram-positive bacteria by self-reporting Janus magnetic nanoparticles. Small17, e2006357. doi:Â 10.1002/smll.202006357
70
HowlinR. P.CathieK.Hall-StoodleyL.CorneliusV.DuignanC.AllanR. N.et al. (2017). Low-dose nitric oxide as targeted anti-biofilm adjunctive therapy to treat chronic Pseudomonas aeruginosa infection in cystic fibrosis. Mol. Ther.25, 2104–2116. doi: 10.1016/j.ymthe.2017.06.021
71
JacksonA. A.DanielsE. F.HammondJ. H.WillgerS. D.HoganD. A. (2014). Global regulator Anr represses PlcH phospholipase activity in Pseudomonas aeruginosa when oxygen is limiting. Microbiol. (Reading)160, 2215–2225. doi: 10.1099/mic.0.081158-0
72
JacksonA. A.GrossM. J.DanielsE. F.HamptonT. H.HammondJ. H.Vallet-GelyI.et al. (2013). Anr and its activation by PlcH activity in Pseudomonas aeruginosa host colonization and virulence. J. Bacteriol195, 3093–3104. doi: 10.1128/JB.02169-12
73
Jacob-DubuissonF.MechalyA.BettonJ.-M.AntoineR. (2018). Structural insights into the signalling mechanisms of two-component systems. Nat. Rev. Microbiol.16, 585–593. doi: 10.1038/s41579-018-0055-7
74
JamesG. A.Ge ZhaoA.UsuiM.UnderwoodR. A.NguyenH.BeyenalH.et al. (2016). Microsensor and transcriptomic signatures of oxygen depletion in biofilms associated with chronic wounds. Wound Repair Regen.24, 373–383. doi: 10.1111/wrr.12401
75
Jiménez OteroF.NewmanD. K.TenderL. M. (2023). Pyocyanin-dependent electrochemical inhibition of Pseudomonas aeruginosa biofilms is synergistic with antibiotic treatment. mBio14, e0070223. doi: 10.1128/mbio.00702-23
76
JoJ.CortezK. L.CornellW. C.Price-WhelanA.DietrichL. E. (2017). An orphan cbb3-type cytochrome oxidase subunit supports Pseudomonas aeruginosa biofilm growth and virulence. Elife6, e30205. doi:Â 10.7554/eLife.30205
77
KaliaD.MereyG.NakayamaS.ZhengY.ZhouJ.LuoY.et al. (2013). Nucleotide, c-di-GMP, c-di-AMP, cGMP, cAMP, (p)ppGpp signaling in bacteria and implications in pathogenesis. Chem. Soc. Rev.42, 305–341. doi: 10.1039/c2cs35206k
78
KayE.HumairB.DénervaudV.RiedelK.SpahrS.EberlL.et al. (2006). Two GacA-dependent small RNAs modulate the quorum-sensing response in Pseudomonas aeruginosa. J. Bacteriol.188, 6026–6033. doi: 10.1128/JB.00409-06
79
KempesC. P.OkegbeC.Mears-ClarkeZ.FollowsM. J.DietrichL. E. P. (2014). Morphological optimization for access to dual oxidants in biofilms. Proc. Natl. Acad. Sci. U.S.A.111, 208–213. doi: 10.1073/pnas.1315521110
80
KimB.ParkJ.-S.ChoiH.-Y.YoonS. S.KimW.-G. (2018). Terrein is an inhibitor of quorum sensing and c-di-GMP in Pseudomonas aeruginosa: a connection between quorum sensing and c-di-GMP. Sci. Rep.8, 8617. doi:Â 10.1038/s41598-018-26974-5
81
KolpenM.HansenC. R.BjarnsholtT.MoserC.ChristensenL. D.van GennipM.et al. (2010). Polymorphonuclear leucocytes consume oxygen in sputum from chronic Pseudomonas aeruginosa pneumonia in cystic fibrosis. Thorax65, 57–62. doi: 10.1136/thx.2009.114512
82
KriegerR.RompfA.SchobertM.JahnD. (2002). The pseudomonas aeruginosa hemA promoter is regulated by anr, dnr, NarL and integration host factor. Mol. Genet. Genom.: MGG267, 409–417. doi: 10.1007/s00438-002-0672-7
83
La RosaR.JohansenH. K.MolinS. (2018). Convergent metabolic specialization through distinct evolutionary paths in pseudomonas aeruginosa. Mbio9, e00269–e00218. doi: 10.1128/mBio.00269-18
84
LeeJ.ZhangL. (2015). The hierarchy quorum sensing network in pseudomonas aeruginosa. Protein Cell6, 26–41. doi: 10.1007/s13238-014-0100-x
85
LiL.MaJ.ChengP.LiM.YuZ.SongX.et al. (2023). Roles of two-component regulatory systems in Klebsiella pneumoniae: Regulation of virulence, antibiotic resistance, and stress responses. Microbiol. Res.272, 127374. doi:Â 10.1016/j.micres.2023.127374
86
LinM.-H.ShuJ.-C.HuangH.-Y.ChengY.-C. (2012). Involvement of iron in biofilm formation by Staphylococcus aureus. PLoS One7, e34388. doi:Â 10.1371/journal.pone.0034388
87
LinX.WuL.LiH.WangS.PengX. (2008). Downregulation of Tsx and OmpW and upregulation of OmpX are required for iron homeostasis in Escherichia coli. J. Proteome Res.7, 1235–1243. doi: 10.1021/pr7005928
88
LineL.AlhedeM.KolpenM.KühlM.CiofuO.BjarnsholtT.et al. (2014). Physiological levels of nitrate support anoxic growth by denitrification of Pseudomonas aeruginosa at growth rates reported in cystic fibrosis lungs and sputum. Front. Microbiol.5. doi: 10.3389/fmicb.2014.00554
89
LinskyM.VitkinY.SegalG. (2020). A novel legionella genomic island encodes a copper-responsive regulatory system and a single Icm/Dot effector protein transcriptionally activated by copper. mBio11, e03232–e03219. doi: 10.1128/mBio.03232-19
90
LuoZ.LuR.ShiT.RuanZ.WangW.GuoZ.et al. (2024). Enhanced bacterial cuproptosis-like death via reversal of hypoxia microenvironment for biofilm infection treatment. Adv. Sci. (Weinh)11, e2308850. doi:Â 10.1002/advs.202308850
91
LüthiE.BaurH.GamperM.BrunnerF.VillevalD.MercenierA.et al. (1990). The arc operon for anaerobic arginine catabolism in Pseudomonas aeruginosa contains an additional gene, arcD, encoding a membrane protein. Gene87, 37–43. doi: 10.1016/0378-1119(90)90493-b
92
MartinL. W.GrayA. R.BrockwayB.LamontI. L. (2023). Pseudomonas aeruginosa is oxygen-deprived during infection in cystic fibrosis lungs, reducing the effectiveness of antibiotics. FEMS Microbiol. Lett.370, fnad076. doi:Â 10.1093/femsle/fnad076
93
MashruwalaA. A.van de GuchteA.BoydJ. M. (2017). Impaired respiration elicits SrrAB-dependent programmed cell lysis and biofilm formation in Staphylococcus aureus. Elife6, e23845. doi:Â 10.7554/eLife.23845
94
MassimelliM. J.BeassoniP. R.ForrelladM. A.BarraJ. L.GarridoM. N.DomenechC. E.et al. (2005). Identification, cloning, and expression of pseudomonas aeruginosa phosphorylcholine phosphatase gene. Curr. Microbiol.50, 251–256. doi: 10.1007/s00284-004-4499-9
95
MavrodiD. V.PeeverT. L.MavrodiO. V.ParejkoJ. A.RaaijmakersJ. M.LemanceauP.et al. (2010). Diversity and evolution of the phenazine biosynthesis pathway. Appl. Environ. Microbiol.76, 866–879. doi: 10.1128/AEM.02009-09
96
McPheeJ. B.TamberS.BainsM.MaierE.GellatlyS.LoA.et al. (2009). The major outer membrane protein OprG of Pseudomonas aeruginosa contributes to cytotoxicity and forms an anaerobically regulated, cation-selective channel. FEMS Microbiol. Lett.296, 241–247. doi: 10.1111/j.1574-6968.2009.01651.x
97
MikkelsenH.BondN. J.SkindersoeM. E.GivskovM.LilleyK. S.WelchM. (2009). Biofilms and type III secretion are not mutually exclusive in pseudomonas aeruginosa. Microbiol. (read. Engl.)155, 687–698. doi: 10.1099/mic.0.025551-0
98
MitrophanovA. Y.GroismanE. A. (2008). Signal integration in bacterial two-component regulatory systems. Genes Dev.22, 2601–2611. doi: 10.1101/gad.1700308
99
O’CallaghanJ.ReenF. J.AdamsC.O’GaraF. (2011). Low oxygen induces the type III secretion system in Pseudomonas aeruginosa via modulation of the small RNAs rsmZ and rsmY. Microbiol. (Reading)157, 3417–3428. doi: 10.1099/mic.0.052050-0
100
OkegbeC.FieldsB. L.ColeS. J.BeierschmittC.MorganC. J.Price-WhelanA.et al. (2017). Electron-shuttling antibiotics structure bacterial communities by modulating cellular levels of c-di-GMP. Proc. Natl. Acad. Sci. U.S.A.114, E5236–E5245. doi: 10.1073/pnas.1700264114
101
PalmerK. L.BrownS. A.WhiteleyM. (2007). Membrane-bound nitrate reductase is required for anaerobic growth in cystic fibrosis sputum. J. bacteriology.189, 4449–4455. doi: 10.1128/JB.00162-07
102
PapaR.ImperliniE.TreccaM.ParisI.VrennaG.ArtiniM.et al. (2023). Virulence of Pseudomonas aeruginosa in cystic fibrosis: relationships between normoxia and anoxia lifestyle. Antibiotics (Basel)13, 1. doi:Â 10.3390/antibiotics13010001
103
ParkJ.-S.ChoiH.-Y.KimW.-G. (2020). The Nitrite Transporter Facilitates Biofilm Formation via Suppression of Nitrite Reductase and Is a New Antibiofilm Target in Pseudomonas aeruginosa. mBio11, e00878–e00820. doi: 10.1128/mBio.00878-20
104
PenesyanA.GillingsM.PaulsenI. T. (2015). Antibiotic discovery: combatting bacterial resistance in cells and in biofilm communities. Molecules20, 5286–5298. doi: 10.3390/molecules20045286
105
PengJ.CaoJ.NgF. M.HillJ. (2017). Pseudomonas aeruginosa develops Ciprofloxacin resistance from low to high level with distinctive proteome changes. J. Proteomics152, 75–87. doi: 10.1016/j.jprot.2016.10.005
106
PulukkodyA. C.YungY. P.DonnarummaF.MurrayK. K.CarlsonR. P.HanleyL. (2021). Spatially resolved analysis of Pseudomonas aeruginosa biofilm proteomes measured by laser ablation sample transfer. PLoS One16, e0250911. doi:Â 10.1371/journal.pone.0250911
107
RadaB.JendrysikM. A.PangL.HayesC. P.YooD.-G.ParkJ. J.et al. (2013). Pyocyanin-enhanced neutrophil extracellular trap formation requires the NADPH oxidase. PLoS One8, e54205. doi:Â 10.1371/journal.pone.0054205
108
RawlingE. G.BrinkmanF. S.HancockR. E. (1998). Roles of the carboxy-terminal half of pseudomonas aeruginosa major outer membrane protein OprF in cell shape, growth in low-osmolarity medium, and peptidoglycan association. J. Bacteriol.180, 3556–3562. doi: 10.1128/JB.180.14.3556-3562.1998
109
RichardsonD. J.BerksB. C.RussellD. A.SpiroS.TaylorC. J. (2001). Functional, biochemical and genetic diversity of prokaryotic nitrate reductases. Cell. Mol. Life Sci.: CMLS58, 165–178. doi: 10.1007/PL00000845
110
RodionovD. A.DubchakI. L.ArkinA. P.AlmE. J.GelfandM. S. (2005). Dissimilatory metabolism of nitrogen oxides in bacteria: comparative reconstruction of transcriptional networks. PLoS Comput. Biol.1, e55. doi:Â 10.1371/journal.pcbi.0010055
111
RömlingU.BalsalobreC. (2012). Biofilm infections, their resilience to therapy and innovative treatment strategies. J. Intern. Med.272, 541–561. doi: 10.1111/joim.12004
112
RömlingU.GalperinM. Y.GomelskyM. (2013). Cyclic di-GMP: the first 25 years of a universal bacterial second messenger. Microbiol. Mol. Biol. reviews: MMBR.77, 1–52. doi: 10.1128/MMBR.00043-12
113
RossiE.La RosaR.BartellJ. A.MarvigR. L.HaagensenJ. A. J.SommerL. M.et al. (2021). Pseudomonas aeruginosa adaptation and evolution in patients with cystic fibrosis. Nat. Rev. Microbiol.19, 331–342. doi: 10.1038/s41579-020-00477-5
114
SakuragiY.KolterR. (2007). Quorum-sensing regulation of the biofilm matrix genes (pel) of Pseudomonas aeruginosa. J. Bacteriol189, 5383–5386. doi: 10.1128/JB.00137-07
115
SaundersS. H.TseE. C. M.YatesM. D.OteroF. J.TrammellS. A.StempE. D. A.et al. (2020). Extracellular DNA promotes efficient extracellular electron transfer by pyocyanin in Pseudomonas aeruginosa biofilms. Cell182, 919–932.e19. doi: 10.1016/j.cell.2020.07.006
116
SawersR. G. (1991). Identification and molecular characterization of a transcriptional regulator from pseudomonas aeruginosa PAO1 exhibiting structural and functional similarity to the FNR protein of escherichia coli. Mol. Microbiol.5, 1469–1481. doi: 10.1111/j.1365-2958.1991.tb00793.x
117
SchaibleB.TaylorC. T.SchafferK. (2012). Hypoxia increases antibiotic resistance in pseudomonas aeruginosa through altering the composition of multidrug efflux pumps. Antimicrob. Agents Chemother.56, 2114–2118. doi: 10.1128/AAC.05574-11
118
SchiesslK. T.HuF.JoJ.NaziaS. Z.WangB.Price-WhelanA.et al. (2019). Phenazine production promotes antibiotic tolerance and metabolic heterogeneity in Pseudomonas aeruginosa biofilms. Nat. Commun.10, 762. doi:Â 10.1038/s41467-019-08733-w
119
SchilcherK.HorswillA. R. (2020). Staphylococcal biofilm development: structure, regulation, and treatment strategies. Microbiol. Mol. Biol. Rev.84, e00026–e00019. doi: 10.1128/MMBR.00026-19
120
SchreiberK.KriegerR.BenkertB.EschbachM.AraiH.SchobertM.et al. (2007). The anaerobic regulatory network required for Pseudomonas aeruginosa nitrate respiration. J. Bacteriol189, 4310–4314. doi: 10.1128/JB.00240-07
121
Scribani RossiC.Barrientos-MorenoL.PaoneA.Cutruzzolà F.PaiardiniA.Espinosa-UrgelM.et al. (2022). Nutrient sensing and biofilm modulation: the example of L-arginine in pseudomonas. Int. J. Mol. Sci.23, 4386. doi: 10.3390/ijms23084386
122
SharmaV.NoriegaC. E.RoweJ. J. (2006). Involvement of NarK1 and NarK2 proteins in transport of nitrate and nitrite in the denitrifying bacterium pseudomonas aeruginosa PAO1. Appl. Environ. Microbiol.72, 695–701. doi: 10.1128/AEM.72.1.695-701.2006
123
SinghP. K.SchaeferA. L.ParsekM. R.MoningerT. O.WelshM. J.GreenbergE. P. (2000). Quorum-sensing signals indicate that cystic fibrosis lungs are infected with bacterial biofilms. Nature407, 762–764. doi: 10.1038/35037627
124
SønderholmM.KraghK. N.KorenK.JakobsenT. H.DarchS. E.AlhedeM.et al. (2017). Pseudomonas aeruginosa aggregate formation in an alginate bead model system exhibits in vivo-like characteristics. Appl. Environ. Microbiol.83, e00113–e00117. doi: 10.1128/AEM.00113-17
125
SonnleitnerE.BläsiU. (2014). Regulation of hfq by the RNA CrcZ in pseudomonas aeruginosa carbon catabolite repression. PLoS Genet.10, e1004440. doi: 10.1371/journal.pgen.1004440
126
SonnleitnerE.GonzalezN.Sorger-DomeniggT.HeebS.RichterA. S.BackofenR.et al. (2011). The small RNA PhrS stimulates synthesis of the Pseudomonas aeruginosa quinolone signal. Mol. Microbiol.80, 868–885. doi: 10.1111/j.1365-2958.2011.07620.x
127
SonnleitnerE.PusicP.WolfingerM. T.BläsiU. (2020). Distinctive regulation of carbapenem susceptibility in pseudomonas aeruginosa by hfq. Front. Microbiol.11. doi: 10.3389/fmicb.2020.01001
128
StojkovaP.SpidlovaP.StulikJ. (2019). Nucleoid-associated protein HU: a lilliputian in gene regulation of bacterial virulence. Front. Cell. Infect. Microbiol.9. doi:Â 10.3389/fcimb.2019.00159
129
StokesJ. M.LopatkinA. J.LobritzM. A.CollinsJ. J. (2019). Bacterial metabolism and antibiotic efficacy. Cell Metab.30, 251–259. doi: 10.1016/j.cmet.2019.06.009
130
StoodleyP.ToelkeN.SchwermerC.de BeerD. (2024). Bioenergetics of simultaneous oxygen and nitrate respiration and nitric oxide production in a Pseudomonas aeruginosa agar colony biofilm. Biofilm7, 100181. doi:Â 10.1016/j.bioflm.2024.100181
131
SuZ.XuD.HuX.ZhuW.KongL.QianZ.et al. (2024). Biodegradable oxygen-evolving metalloantibiotics for spatiotemporal sono-metalloimmunotherapy against orthopaedic biofilm infections. Nat. Commun.15, 8058. doi:Â 10.1038/s41467-024-52489-x
132
TaylorS. J.WinterS. E. (2020). Salmonella finds a way: Metabolic versatility of Salmonella enterica serovar Typhimurium in diverse host environments. PLoS Pathog.16, e1008540. doi:Â 10.1371/journal.ppat.1008540
133
TengT.XiB.ChenK.PanL.XieJ.XuP. (2018). Comparative transcriptomic and proteomic analyses reveal upregulated expression of virulence and iron transport factors of Aeromonas hydrophila under iron limitation. BMC Microbiol.18, 52. doi:Â 10.1186/s12866-018-1178-8
134
TierneyA. R.RatherP. N. (2019). Roles of two-component regulatory systems in antibiotic resistance. Future Microbiol.14, 533–552. doi: 10.2217/fmb-2019-0002
135
TrunkK.BenkertB.QuäckN.MünchR.ScheerM.GarbeJ.et al. (2010). Anaerobic adaptation in Pseudomonas aeruginosa: definition of the Anr and Dnr regulons. Environ. Microbiol.12, 1719–1733. doi: 10.1111/j.1462-2920.2010.02252.x
136
UedaA.WoodT. K. (2009). Connecting quorum sensing, c-di-GMP, pel polysaccharide, and biofilm formation in pseudomonas aeruginosa through tyrosine phosphatase TpbA (PA3885). PLoS Pathog.5, e1000483. doi:Â 10.1371/journal.ppat.1000483
137
Vander WauvenC.PiérardA.Kley-RaymannM.HaasD. (1984). Pseudomonas aeruginosa mutants affected in anaerobic growth on arginine: evidence for a four-gene cluster encoding the arginine deiminase pathway. J. Bacteriol160, 928–934. doi: 10.1128/jb.160.3.928-934.1984
138
VentreI.GoodmanA. L.Vallet-GelyI.VasseurP.SosciaC.MolinS.et al. (2006). Multiple sensors control reciprocal expression of Pseudomonas aeruginosa regulatory RNA and virulence genes. Proc. Natl. Acad. Sci. U.S.A.103, 171–176. doi: 10.1073/pnas.0507407103
139
VestbyL. K.GrønsethT.SimmR.NesseL. L. (2020). Bacterial biofilm and its role in the pathogenesis of disease. Antibiotics (Basel)9, 59. doi: 10.3390/antibiotics9020059
140
WagnerV. E.IglewskiB. H. (2008). P. aeruginosa biofilms in CF infection. Clin. Rev. Allergy Immunol.35, 124–134. doi: 10.1007/s12016-008-8079-9
141
WangZ.LiuX.DuanY.HuangY. (2022). Infection microenvironment-related antibacterial nanotherapeutic strategies. Biomaterials280, 121249. doi:Â 10.1016/j.biomaterials.2021.121249
142
WangY.NewmanD. K. (2008). Redox reactions of phenazine antibiotics with ferric (hydr)oxides and molecular oxygen. Environ. Sci. Technol.42, 2380–2386. doi: 10.1021/es702290a
143
WernerE.RoeF.BugnicourtA.FranklinM. J.HeydornA.MolinS.et al. (2004). Stratified growth in Pseudomonas aeruginosa biofilms. Appl. Environ. Microbiol.70, 6188–6196. doi: 10.1128/AEM.70.10.6188-6196.2004
144
WilliamsH. D.ZlosnikJ. E. A.RyallB. (2007). Oxygen, cyanide and energy generation in the cystic fibrosis pathogen pseudomonas aeruginosa. Adv. Microb. Physiol.52, 1–71. doi: 10.1016/S0065-2911(06)52001-6
145
WuM.ChenC.LiuZ.TianJ.ZhangW. (2022). Regulating the bacterial oxygen microenvironment via a perfluorocarbon-conjugated bacteriochlorin for enhanced photodynamic antibacterial efficacy. Acta Biomater142, 242–252. doi: 10.1016/j.actbio.2022.02.013
146
XiuW.GanS.WenQ.QiuQ.DaiS.DongH.et al. (2020). Biofilm microenvironment-responsive nanotheranostics for dual-mode imaging and hypoxia-relief-enhanced photodynamic therapy of bacterial infections. Res. (Wash D C)2020, 9426453. doi:Â 10.34133/2020/9426453
147
XuK. D.StewartP. S.XiaF.HuangC. T.McFetersG. A. (1998). Spatial physiological heterogeneity in Pseudomonas aeruginosa biofilm is determined by oxygen availability. Appl. Environ. Microbiol.64, 4035–4039. doi: 10.1128/AEM.64.10.4035-4039.1998
148
YoonS. S.HenniganR. F.HilliardG. M.OchsnerU. A.ParvatiyarK.KamaniM. C.et al. (2002). Pseudomonas aeruginosa anaerobic respiration in biofilms: relationships to cystic fibrosis pathogenesis. Dev. Cell3, 593–603. doi: 10.1016/s1534-5807(02)00295-2
149
YoonM. Y.LeeK.-M.ParkY.YoonS. S. (2011). Contribution of cell elongation to the biofilm formation of pseudomonas aeruginosa during anaerobic respiration. PLoS One6, e16105. doi:Â 10.1371/journal.pone.0016105
150
Zamudio-ChávezL.SuescaE.LópezG. D.CarazzoneC.Manrique-MorenoM.LeidyC. (2023). Staphylococcus aureus modulates carotenoid and phospholipid content in response to oxygen-restricted growth conditions, triggering changes in membrane biophysical properties. Int. J. Mol. Sci.24, 14906. doi: 10.3390/ijms241914906
151
ZhangY.HanK.ChandlerC. E.TjadenB.ErnstR. K.LoryS. (2017). Probing the sRNA regulatory landscape of P. aeruginosa: post-transcriptional control of determinants of pathogenicity and antibiotic susceptibility. Mol. Microbiol.106, 919–937. doi: 10.1111/mmi.13857
152
ZhaoA.SunJ.LiuY. (2023a). Understanding bacterial biofilms: From definition to treatment strategies. Front. Cell Infect. Microbiol.13. doi:Â 10.3389/fcimb.2023.1137947
153
ZhaoH.ZhaoC.LiuZ.YiJ.LiuX.RenJ.et al. (2023b). A polyoxometalate-based pathologically activated assay for efficient bioorthogonal catalytic selective therapy. Angew Chem. Int. Ed Engl.62, e202303989. doi:Â 10.1002/anie.202303989
Summary
Keywords
biofilms, oxygen-limited, anaerobic metabolism, transcriptional factors, two-component systems, quorum sensing, Pseudomonas aeruginosa
Citation
Ren L, Yuan Y, Farea K, Feng X, He J, Liu Y and Zheng B (2025) The adaptability of Pseudomonas aeruginosa biofilm in oxygen-limited environments. Front. Cell. Infect. Microbiol. 15:1655335. doi: 10.3389/fcimb.2025.1655335
Received
27 June 2025
Accepted
03 September 2025
Published
19 September 2025
Volume
15 - 2025
Edited by
Ashwini Chauhan, University of Delhi, India
Updates
Copyright
© 2025 Ren, Yuan, Farea, Feng, He, Liu and Zheng.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Yi Liu, liuyi@cmu.edu.cn; Bowen Zheng, bwzheng@cmu.edu.cn
†These authors have contributed equally to this work and share first authorship
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.